Dsp Healthcare Fund Overview | ||||||
---|---|---|---|---|---|---|
Category | Pharma Fund | |||||
BMSMONEY Rank | - | |||||
BMSMONEY Rating | ||||||
Gro. Opt. | As On: | 20-12-2024 | ||||
NAV | ₹40.79(R) | -1.03% | ₹44.68(D) | -1.02% | ||
Returns | 1Y | 3Y | 5Y | 7Y | 10Y | |
LumpSum (R) | 42.48% | 23.06% | 30.74% | -% | -% | |
LumpSum (D) | 44.41% | 24.74% | 32.66% | -% | -% | |
SIP (R) | -19.67% | 29.26% | 26.13% | -% | -% | |
SIP (D) | -18.47% | 31.07% | 27.9% | -% | -% | |
Ratio | Sharpe Ratio | Sortino Ratio | Sterling Ratio | Jensen's Alpha | Treynor Ratio | |
0.96 | 0.52 | 0.79 | 5.82% | 0.17 | ||
Risk | STD. Dev | VaR 1Y95% | Max DD | Beta | Semi Devi. | |
15.65% | -17.66% | -18.92% | 0.9 | 10.86% |
NAV Date: 20-12-2024
Scheme Name | NAV | Rupee Change | Percent Change |
---|---|---|---|
DSP Healthcare Fund - Regular Plan - IDCW | 28.04 |
-0.2900
|
-1.0200%
|
DSP Healthcare Fund - Direct Plan - IDCW | 30.64 |
-0.3200
|
-1.0200%
|
DSP Healthcare Fund - Regular Plan - Growth | 40.79 |
-0.4200
|
-1.0300%
|
DSP Healthcare Fund - Direct Plan - Growth | 44.68 |
-0.4600
|
-1.0200%
|
Review Date: 20-12-2024
A review of the different performance parameters of the fund is as follows:KPIs* | Fund | Benchmark | Cat. Avg | Min | Max | Rank (In Cat.) | Performance |
---|---|---|---|---|---|---|
1M Return % | 0.53 |
2.88
|
-0.97 | 4.52 | 12 | 13 | Average | |
3M Return % | 0.18 |
-0.40
|
-9.73 | 3.09 | 6 | 13 | Good | |
6M Return % | 23.92 |
19.11
|
3.40 | 26.27 | 3 | 13 | Very Good | |
1Y Return % | 42.48 |
42.49
|
33.84 | 51.93 | 6 | 12 | Good | |
3Y Return % | 23.06 |
22.41
|
19.56 | 25.88 | 3 | 8 | Good | |
5Y Return % | 30.74 |
28.25
|
24.23 | 30.74 | 1 | 8 | Very Good | |
1Y SIP Return % | -19.67 |
-21.85
|
-35.24 | -12.91 | 5 | 12 | Good | |
3Y SIP Return % | 29.26 |
28.17
|
25.24 | 32.64 | 4 | 8 | Good | |
5Y SIP Return % | 26.13 |
24.81
|
21.75 | 27.67 | 3 | 8 | Good | |
Standard Deviation | 15.65 |
15.42
|
14.47 | 16.13 | 5 | 8 | Average | |
Semi Deviation | 10.86 |
10.54
|
10.13 | 10.91 | 7 | 8 | Poor | |
Max Drawdown % | -18.92 |
-16.50
|
-18.92 | -14.27 | 8 | 8 | Poor | |
VaR 1 Y % | -17.66 |
-16.74
|
-18.91 | -14.68 | 7 | 8 | Poor | |
Average Drawdown % | -4.79 |
-5.35
|
-6.76 | -4.22 | 3 | 8 | Good | |
Sharpe Ratio | 0.96 |
0.88
|
0.66 | 1.12 | 3 | 8 | Good | |
Sterling Ratio | 0.79 |
0.80
|
0.66 | 1.02 | 4 | 8 | Good | |
Sortino Ratio | 0.52 |
0.48
|
0.36 | 0.65 | 3 | 8 | Good | |
Jensen Alpha % | 5.82 |
4.05
|
0.12 | 8.16 | 3 | 8 | Good | |
Treynor Ratio | 0.17 |
0.15
|
0.11 | 0.19 | 3 | 8 | Good | |
Modigliani Square Measure % | 23.74 |
22.51
|
18.32 | 27.03 | 3 | 8 | Good | |
Alpha % | 4.04 |
2.41
|
-0.61 | 6.00 | 3 | 8 | Good |
KPIs* | Fund | Benchmark | Cat. Avg | Min | Max | Rank (In Cat.) | Performance |
---|---|---|---|---|---|---|
1M Return % | 0.64 | 2.99 | -0.84 | 4.64 | 12 | 13 | ||
3M Return % | 0.51 | -0.08 | -9.36 | 3.54 | 6 | 13 | ||
6M Return % | 24.76 | 19.88 | 4.26 | 27.36 | 3 | 13 | ||
1Y Return % | 44.41 | 44.30 | 36.04 | 53.85 | 7 | 12 | ||
3Y Return % | 24.74 | 23.89 | 21.29 | 27.00 | 3 | 8 | ||
5Y Return % | 32.66 | 29.86 | 26.17 | 32.66 | 1 | 8 | ||
1Y SIP Return % | -18.47 | -20.75 | -34.00 | -11.70 | 5 | 12 | ||
3Y SIP Return % | 31.07 | 29.75 | 27.01 | 33.82 | 3 | 8 | ||
5Y SIP Return % | 27.91 | 26.34 | 23.54 | 28.81 | 2 | 8 | ||
Standard Deviation | 15.65 | 15.42 | 14.47 | 16.13 | 5 | 8 | ||
Semi Deviation | 10.86 | 10.54 | 10.13 | 10.91 | 7 | 8 | ||
Max Drawdown % | -18.92 | -16.50 | -18.92 | -14.27 | 8 | 8 | ||
VaR 1 Y % | -17.66 | -16.74 | -18.91 | -14.68 | 7 | 8 | ||
Average Drawdown % | -4.79 | -5.35 | -6.76 | -4.22 | 3 | 8 | ||
Sharpe Ratio | 0.96 | 0.88 | 0.66 | 1.12 | 3 | 8 | ||
Sterling Ratio | 0.79 | 0.80 | 0.66 | 1.02 | 4 | 8 | ||
Sortino Ratio | 0.52 | 0.48 | 0.36 | 0.65 | 3 | 8 | ||
Jensen Alpha % | 5.82 | 4.05 | 0.12 | 8.16 | 3 | 8 | ||
Treynor Ratio | 0.17 | 0.15 | 0.11 | 0.19 | 3 | 8 | ||
Modigliani Square Measure % | 23.74 | 22.51 | 18.32 | 27.03 | 3 | 8 | ||
Alpha % | 4.04 | 2.41 | -0.61 | 6.00 | 3 | 8 |
Investment Period | Regular | Direct | ||
---|---|---|---|---|
Return % | Current Value of ₹ 10000 | Return % | Current Value of ₹ 10000 | |
1D | -1.03 | ₹ 9,897.00 | -1.02 | ₹ 9,898.00 |
1W | -1.00 | ₹ 9,900.00 | -0.97 | ₹ 9,903.00 |
1M | 0.53 | ₹ 10,053.00 | 0.64 | ₹ 10,064.00 |
3M | 0.18 | ₹ 10,018.00 | 0.51 | ₹ 10,051.00 |
6M | 23.92 | ₹ 12,392.00 | 24.76 | ₹ 12,476.00 |
1Y | 42.48 | ₹ 14,248.00 | 44.41 | ₹ 14,441.00 |
3Y | 23.06 | ₹ 18,634.00 | 24.74 | ₹ 19,408.00 |
5Y | 30.74 | ₹ 38,205.00 | 32.66 | ₹ 41,093.00 |
7Y | ₹ | ₹ | ||
10Y | ₹ | ₹ | ||
15Y | ₹ | ₹ |
Disclaimer: Past performance may or may not be sustained in future and should not be used as a basis for comparison with other investments. Returns for periods above 1 year are annualised.
Investment Period | Invested Amount | Regular | Direct | ||
---|---|---|---|---|---|
XIRR % | Current Value of Invested Amount | XIRR % | Current Value of Invested Amount | ||
1Y | ₹ 12000 | -19.67 | ₹ 10,679.54 | -18.47 | ₹ 10,762.51 |
3Y | ₹ 36000 | 29.26 | ₹ 54,828.86 | 31.07 | ₹ 56,168.78 |
5Y | ₹ 60000 | 26.13 | ₹ 114,490.44 | 27.91 | ₹ 119,429.40 |
7Y | ₹ 84000 | ₹ | ₹ | ||
10Y | ₹ 120000 | ₹ | ₹ | ||
15Y | ₹ 180000 | ₹ | ₹ |
Date | Dsp Healthcare Fund NAV Regular Growth | Dsp Healthcare Fund NAV Direct Growth |
---|---|---|
20-12-2024 | 40.791 | 44.68 |
19-12-2024 | 41.214 | 45.141 |
18-12-2024 | 41.11 | 45.025 |
17-12-2024 | 41.148 | 45.065 |
16-12-2024 | 41.254 | 45.18 |
13-12-2024 | 41.201 | 45.117 |
12-12-2024 | 41.281 | 45.203 |
11-12-2024 | 41.624 | 45.577 |
10-12-2024 | 41.502 | 45.442 |
09-12-2024 | 41.456 | 45.389 |
06-12-2024 | 41.575 | 45.515 |
05-12-2024 | 41.615 | 45.557 |
04-12-2024 | 41.613 | 45.553 |
03-12-2024 | 41.64 | 45.58 |
02-12-2024 | 41.643 | 45.583 |
29-11-2024 | 41.482 | 45.401 |
27-11-2024 | 40.922 | 44.785 |
26-11-2024 | 41.169 | 45.054 |
25-11-2024 | 41.334 | 45.233 |
22-11-2024 | 41.099 | 44.97 |
21-11-2024 | 40.574 | 44.395 |
Fund Launch Date: 12/Nov/2018 |
Fund Category: Pharma Fund |
Investment Objective: The primary investment objective of the scheme is to seek to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies. However, there can be no assurance that the investment objective of the scheme will be realized. |
Fund Description: An open ended equity scheme investing in healthcare and pharmaceutical sector |
Fund Benchmark: S&P BSE HEALTHCARE (Total Return Index) |
Disclaimer: NO INVESTMENT ADVICE. The Content is for informational purposes only.